Chagas disease and endomyocardial fibrosis represent two examples ... These two diseases have many specific features but share others with the usual forms of dilated and restrictive cardiomyopathy in ...

Instituto Nacional de Infectologia Evandro Chagas (INI ... trauma, gynecologic disease, toxicities, others, and sings and symptoms. Socio-demographic and clinical features were compared among included ...

Rapid tests could be used to diagnose Chagas disease in resource-limited areas, according to a study led by the Barcelona Institute for Global Health (ISGlobal). The results of this research, ...

Rapid tests could be used to diagnose Chagas disease in resource-limited areas. The results of this research show that the prevalence of Chagas in an indigenous community in Paraguay is six times ...

In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid ...

PAHO said leprosy, dengue, Chagas disease, leishmaniasis, rabies, scabies, schistosomiasis and trachoma are among the more than 20 diseases that primarily impact vulnerable populations with ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

In 2022, more than 941,600 Americans died from cardiovascular disease. Heart disease remains the leading cause of death in the United States, according to a new report. The American Heart ...

A Tropical Disease Priority Review Voucher was awarded ... 5 Ribas Freitas AR, Pinheiro Chagas AA, Siqueira AM, Pamplona de Góes Cavalcanti L. How much of the current serious arbovirus epidemic ...

This new multimodal feature works in conjunction with Gemini’s app extensions. A handful of Google apps (and now select Samsung apps) feed into the AI’s responses, including Workspace apps ...

A small number of people report chronic symptoms after receiving COVID-19 shots. A new study provides clues for further research.

The Swiss pharma group says it has earmarked $100 million for new treatments for Chagas disease, leishmaniasis, dengue fever and cryptosporidiosis, with $150 million going towards new antimalarial ...